Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: Results of a randomized, open-label study

Contraception

Volumn 87, Issue 2, 2013, Pages 227-234

  Endrikat, Jan ^a,b   Parke, Susanne ^a   Trummer, Dietmar ^a   Serrani, Marco ^a   Duijkers, Ingrid ^c   Klipping, Christine ^c  

^a BAYER PHARMA AG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Dinox BV   (Netherlands)

Author keywords

Cervical mucus; Dienogest; Endometrial thickness; Estradiol valerate; Ovarian

Indexed keywords

DIENOGEST PLUS ESTRADIOL VALERATE; ESTRADIOL VALERATE; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIAL THICKNESS; FEMALE; GONADOTROPIN BLOOD LEVEL; HORMONAL CONTRACEPTION; HUMAN; HYPOPHYSIS; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; OVARY; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX MUCUS;

ADOLESCENT; ADULT; CERVIX MUCUS; CONTRACEPTIVES, ORAL, COMBINED; ENDOMETRIUM; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; NANDROLONE; OVARY; OVULATION; PITUITARY GLAND; PROGESTERONE;

EID: 84872151417     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.07.008     Document Type: Article

References (25)

1. G. Csemiczky, T. Dieben, H.J. Coeling Bennink, and B.M. Landgren The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days Contraception 54 1996 333 338 (Pubitemid 26412416)
2. W. Schubert, and G. Cullberg Ovulation inhibition with 17 beta-estradiol cyclo-octyl acetate and desogestrel Acta Obstet Gynecol Scand 66 1987 543 547 (Pubitemid 18014725)
3. J. Serup, E. Bostofte, S. Larsen, J. Westergaard, and P.E. Lebech Natural oestrogens for oral contraception Lancet 2 1979 471 472 (Pubitemid 9250419)
4. J. Spona, W. Feichtinger, and C. Kindermann Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest Contraception 56 1997 185 191 (Pubitemid 27450831)
5. S. Palacios, L. Wildt, S. Parke, A. Machlitt, T. Romer, and J. Bitzer Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a phase III trial Eur J Obstet Gynecol Reprod Biol 149 2010 57 62
6. R. Rivera, I. Yacobson, and D. Grimes The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices Am J Obstet Gynecol 181 1999 1263 1269
7. J. Endrikat, S. Parke, D. Trummer, W. Schmidt, I. Duijkers, and C. Klipping Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies Contraception 78 2008 218 225
8. P.L.C. Bayer, and U.K. Newbury Qlaira® summary of product characteristics http://www.medicines.org.uk/emc/medicine/21700/SPC/qlaira/ 2011 Accessed 03 February, 2012
9. I.J. Duijkers, and C. Klipping Ultrasonographic assessment of endocervix and cervical mucus in ovulatory menstrual cycles Eur J Obstet Gynecol Reprod Biol 93 2000 13 17
10. I. Wolman, T.B. Gal, and A.J. Jaffa Cervical mucus status can be accurately estimated by transvaginal ultrasound during fertility evaluation Fertil Steril 92 2009 1165 1167
11. S. Zeun, M. Lu, A. Uddin, B. Zeiler, D. Morrison, and H. Blode Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest Eur J Contracept Reprod Health Care 14 2009 221 232
12. P.J. Sulak, R.D. Scow, C. Preece, M.W. Riggs, and T.J. Kuehl Hormone withdrawal symptoms in oral contraceptive users Obstet Gynecol 95 2000 261 266 (Pubitemid 30045651)
13. C. Klipping, I. Duijkers, D. Trummer, and J. Marr Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen Contraception 78 2008 16 25
14. J. Spona, M. Elstein, and W. Feichtinger Shorter pill-free interval in combined oral contraceptives decreases follicular development Contraception 54 1996 71 77 (Pubitemid 26256707)
15. I.J. Duijkers, C. Klipping, P. Grob, and T. Korver Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol Eur J Contracept Reprod Health Care 15 2010 314 325
16. D.R. Grow, and K. Iromloo Oral contraceptives maintain a very thin endometrium before operative hysteroscopy Fertil Steril 85 2006 204 207 (Pubitemid 43063446)
17. F. Ludicke, E. Johannisson, F.M. Helmerhorst, A. Campana, J. Foidart, and R. Heithecker Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium Fertil Steril 76 2001 102 107 (Pubitemid 32600966)
18. T. Rabe, D.C. Nitsche, and B. Runnebaum The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness Eur J Contracept Reprod Health Care 2 1997 39 51 (Pubitemid 127497257)
19. J. Spona, N. Binder, K. Hoschen, and W. Feichtinger Contraceptive efficacy and safety of a low-dose oral contraceptive, (0.03 mg ethinyl oestradiol and 2 mg chlormadinone acetate) Belara, over three medication cycles Eur J Contracept Reprod Health Care 13 2008 39 48 (Pubitemid 351271855)
20. J. Spona, N. Binder, K. Hoschen, and W. Feichtinger Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles Fertil Steril 94 2009 1195 1201
21. P. Kovacs, S. Matyas, K. Boda, and S.G. Kaali The effect of endometrial thickness on IVF/ICSI outcome Hum Reprod 18 2003 2337 2341 (Pubitemid 37427814)
22. H.I. Abdalla, A.A. Brooks, M.R. Johnson, A. Kirkland, A. Thomas, and J.W. Studd Endometrial thickness: a predictor of implantation in ovum recipients? Hum Reprod 9 1994 363 365 (Pubitemid 24076764)
23. R.L. Schild, C. Knobloch, C. Dorn, R. Fimmers, H. van Der Ven, and M. Hansmann Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow Fertil Steril 75 2001 361 366 (Pubitemid 32112115)
24. S. Bassil Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization Ultrasound Obstet Gynecol 18 2001 258 263 (Pubitemid 32830499)
25. D.B. Dunson, I. Sinai, and B. Colombo The relationship between cervical secretions and the daily probabilities of pregnancy: effectiveness of the TwoDay Algorithm Hum Reprod 16 2001 2278 2282 (Pubitemid 33054122)